NJ AJR120

Designates the first full week of May each year as "Tardive Dyskinesia Awareness Week" in New Jersey to encourage residents to identify symptoms and risk factors of the disorder

Tardive Dyskinesia (TD) is a persistent, potentially irreversible neurological condition causing uncontrollable repetitive movements, affecting approximately 600,000 people in the U.S., with about 70% undiagnosed

TD is caused by dopamine receptor blocking agents (DRBAs), including antipsychotics prescribed for schizophrenia, bipolar disorder, major depression, and gastrointestinal disorders

Approximately 1.1 million adults in New Jersey (16.14% of adults) live with mental illness and may receive DRBA treatment that can lead to TD onset

Requests the Governor to annually issue a proclamation recognizing the awareness week to promote early screening, diagnosis, and treatment